公司資料
Agenus 股價、新聞與催化劑
- 股票代碼:
- AGEN
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
7.67 USD (-5.19%)
收盤價
最後更新: 2026年8月24日
141M USD
市值
股價為何變動
As of Aug 24, 2026, AGEN closed down 5.19% at $7.67. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Agenus is an immuno-oncology company focused on cancer immunotherapy, including checkpoint and combination approaches. The company has spent years trying to turn immune science into a durable oncology franchise.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Agenus sits in specialty oncology biotechnology.
商業模式特徵
The business depends on clinical data, strategic partnerships, and the ability to translate immunotherapy science into value.
生技產業定位
Agenus is a high-risk oncology name whose valuation is heavily dependent on clinical and strategic milestones.
未來催化劑
- Agenus's catalysts are botensilimab and balstilimab combination data, plus any partnering progression that can de-risk the program. The company still needs proof that the immuno-oncology story can keep moving.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。